In October IFCC has planned two complimentary webinars:
| “Common laboratory measures of dysglycaemia;
Their strengths and weaknesses” 27th October, 2021 The webinar will last 90 minutes Register at: https://www.workcast.com/register?cpak=4552903128838838
Time Zones: Live presentations starting at 6PM Sydney-AEDT; 9:00 AM Milan CEST; 3:00 AM US-EDT Important: Please ensure that you carefully determine the time that the presentation will start in your global time zone.
Diabetes Mellitus, and its precursor clinical syndromes, continue to grow in prevalence in developed and developing countries across the world. Until we have better strategies for prevention, we rely on laboratory testing to screen, diagnose and manage these conditions. The Webinar will consist of three talks (20 minutes each) and will be followed by the panel discussion – Registrants will be able to ask questions to the presenters. Chair: Dr. Tina Yen (Australia)
Talk 1: Laboratory measurement of glucose Speaker: Dr. Greg Ward (Australia)
Talk 2: Insulin analysis in hyperglycemia Speaker: Dr. Paul Williams (Australia)
Talk 3: HbA1c – still the gold standard? Speaker: Dr. Ken Sikaris (Australia)
|
“Alzheimer’s disease therapeutics & biofluid tests:
Current practice and future prospects” 28th October 2021 The webinar will last 90 minutes Register at: https://www.workcast.com/register?cpak=5390610616631173
Time Zones: 9:30 AM Pacific Time, 6:30 PM European Time, 13:30 PM Argentina Time Important: Please ensure that you carefully determine the time that the presentation will start in your global time zone.
This session will provide an overview of the rapidly evolving landscape of: (i) the use, reporting and interpretation of cerebrospinal fluid (CSF) Alzheimer’s disease biomarkers in clinical care, (ii) the development of peripheral (i.e.,blood-based) biomarkers and assays for Alzheimer’s disease, and (iii) the state of disease-modifying therapeutics for Alzheimer’s disease, including current and future uses of biomarkers related to therapeutics. The Webinar will consist of three talks (20 minutes each) and will be followed by the panel discussion – Registrants will be able to ask questions to the presenters. Chair: Dr. Robert Rissman (USA)
Talk 1: A primer on Alzheimer’s neuropathology and current treatments Speaker: Dr. Haakon B. Nygaard (Canada)
Talk 2: Clinical implementation of CSF biomarkers for Alzheimer’s disease Speaker: Dr. Mari DeMarco (Canada)
Talk 3: Blood-based biomarkers of Alzheimer’s disease Speaker: Dr. Melissa Budelier (USA) |
- Recorded webinar: available on demand
- Certificate of Participation: available for all registrants
- The attached invitation can be shared for easier registration.
